1-7 of 7
Paola Dal Cin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies

Open Access
Melissa Zhao, Scott Ryall, Samuel J. Brody, Amyah C. Harris, Kristin Cabral, Catherine Brownstein, Jaeseung C. Kim, Adam C. Smith, Paola Dal Cin, Rupa Narayan, Kristin Sikkink, Anthony Schmitt, Gabriela S. Hobbs, Amir T. Fathi, Gabriel K. Griffin, Sheila N. J. Sait, Anthony J. Iafrate, Jon C. Aster, Timothy A. Graubert, Valentina Nardi, Adrian M. Dubuc
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1003–1012.
https://doi.org/10.1182/bloodadvances.2024013800
Published: 2025
Includes: Supplemental data
Journal Articles

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Free
Clinical Trials & Observations
Olga K. Weinberg, Alexa Siddon, Yazan F. Madanat, Jeffrey Gagan, Daniel A. Arber, Paola Dal Cin, Damodaran Narayanan, Madhu M. Ouseph, Jason H. Kurzer, Robert P. Hasserjian
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2847–2853.
https://doi.org/10.1182/bloodadvances.2021006239
Published: 2022
Includes: Supplemental data
Journal Articles

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Free
Sarah B. Mueller, Paola Dal Cin, Long P. Le, Dora Dias-Santagata, Jochen K. Lennerz, A. John Iafrate, Hetal Desai Marble, Andrew M. Brunner, Matthew J. Weinstock, Marlise R. Luskin, Daniel J. De Angelo, Richard M. Stone, Valentina Nardi
Journal: Blood Advances
Blood Adv (2022) 6 (3): 818–827.
https://doi.org/10.1182/bloodadvances.2021005280
Published: 2022
Includes: Supplemental data
Journal Articles

Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

Free
Clinical Trials & Observations
Monica Kasbekar, Valentina Nardi, Paola Dal Cin, Andrew M. Brunner, Meghan Burke, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, Julia Foster, Molly Macrae, Steven L. McAfee, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, Meghan Vartanian, Robb S. Friedman, Karim A. Benhadji, Gabriela S. Hobbs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3136–3140.
https://doi.org/10.1182/bloodadvances.2020002308
Published: 2020
Journal Articles

A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia

Free
Clinical Trials & Observations
Max Jan, Daniel E. Grinshpun, Julian A. Villalba, Paola Dal Cin, David B. Sykes, A. John Iafrate, Benjamin L. Ebert, Gabriela S. Hobbs, Valentina Nardi
Journal: Blood Advances
Blood Adv (2020) 4 (3): 445–448.
https://doi.org/10.1182/bloodadvances.2019001182
Published: 2020
Journal Articles

Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement

Free
Clinical Trials & Observations
Valentina Nardi, Nora Ku, Matthew J. Frigault, Adrian M. Dubuc, Harrison Kwei Tsai, Philip C. Amrein, Gabriela S. Hobbs, Andrew M. Brunner, Rupa Narayan, Meghan E. Burke, Julia Foster, Paola Dal Cin, Marcela V. Maus, Amir T. Fathi, Hanno Hock
Journal: Blood Advances
Blood Adv (2020) 4 (1): 106–111.
https://doi.org/10.1182/bloodadvances.2019000769
Published: 2020
Includes: Supplemental data
Journal Articles

Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening

Free
Clinical Trials & Observations
Marlise R. Luskin, Marie N. Discenza, Sarah Rae Easter, Paola Dal Cin, Renius Owen, Bernard Ilagan, Meredith Masiello, Andrew A. Lane
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1491–1494.
https://doi.org/10.1182/bloodadvances.2017008680
Published: 2017